PL323669A1 - Application of alendronate in osteoporosis prevention - Google Patents

Application of alendronate in osteoporosis prevention

Info

Publication number
PL323669A1
PL323669A1 PL96323669A PL32366996A PL323669A1 PL 323669 A1 PL323669 A1 PL 323669A1 PL 96323669 A PL96323669 A PL 96323669A PL 32366996 A PL32366996 A PL 32366996A PL 323669 A1 PL323669 A1 PL 323669A1
Authority
PL
Poland
Prior art keywords
alendronate
application
osteoporosis prevention
osteoporosis
prevention
Prior art date
Application number
PL96323669A
Other languages
English (en)
Inventor
Ashley J Yetes
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of PL323669A1 publication Critical patent/PL323669A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL96323669A 1995-06-02 1996-05-29 Application of alendronate in osteoporosis prevention PL323669A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45819595A 1995-06-02 1995-06-02

Publications (1)

Publication Number Publication Date
PL323669A1 true PL323669A1 (en) 1998-04-14

Family

ID=23819759

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96323669A PL323669A1 (en) 1995-06-02 1996-05-29 Application of alendronate in osteoporosis prevention

Country Status (21)

Country Link
EP (1) EP0828496A1 (ja)
JP (1) JPH10506648A (ja)
KR (1) KR19990022436A (ja)
CN (1) CN1192685A (ja)
AU (1) AU709196B2 (ja)
BG (1) BG63103B1 (ja)
BR (1) BR9609020A (ja)
CA (1) CA2222318A1 (ja)
CZ (1) CZ381197A3 (ja)
EA (1) EA000677B1 (ja)
EE (1) EE03306B1 (ja)
HU (1) HUP9900659A3 (ja)
IL (1) IL118422A0 (ja)
IS (1) IS4617A (ja)
NO (1) NO975527D0 (ja)
NZ (1) NZ308935A (ja)
PL (1) PL323669A1 (ja)
SK (1) SK159597A3 (ja)
TR (1) TR199701482T1 (ja)
WO (1) WO1996038156A1 (ja)
ZA (1) ZA964465B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
KR100317935B1 (ko) * 1999-10-20 2001-12-22 유승필 대사성 골질환 치료용 약제조성물 및 이의 제조방법
PT1392325E (pt) * 2001-05-02 2006-10-31 Novartis Ag Metodo de administracao de bifosfonatos por inalacao no tratamento ou na prevencao da reabsorcao ossea e da osteoporose
JP2010043119A (ja) * 2009-10-16 2010-02-25 Gador Sa 骨の代謝病の予防および/または治療のための組成物、その組成物の調製方法およびその使用
KR102472749B1 (ko) * 2022-01-18 2022-12-02 주식회사 위엔씨 유해가스제거 및 항균탈취기능을 함유한 흡착소재 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations

Also Published As

Publication number Publication date
CA2222318A1 (en) 1996-12-05
AU5882496A (en) 1996-12-18
NO975527L (no) 1997-12-01
NZ308935A (en) 2000-07-28
IS4617A (is) 1997-11-19
AU709196B2 (en) 1999-08-26
KR19990022436A (ko) 1999-03-25
SK159597A3 (en) 1998-06-03
EP0828496A1 (en) 1998-03-18
HUP9900659A2 (hu) 2001-04-28
BR9609020A (pt) 1999-07-06
BG102060A (en) 1998-07-31
BG63103B1 (bg) 2001-04-30
CN1192685A (zh) 1998-09-09
HUP9900659A3 (en) 2002-12-28
TR199701482T1 (xx) 1998-03-21
EA000677B1 (ru) 2000-02-28
CZ381197A3 (cs) 1998-06-17
NO975527D0 (no) 1997-12-01
IL118422A0 (en) 1996-09-12
ZA964465B (en) 1996-12-11
JPH10506648A (ja) 1998-06-30
WO1996038156A1 (en) 1996-12-05
EE03306B1 (et) 2000-12-15
EA199700449A1 (ru) 1998-06-25

Similar Documents

Publication Publication Date Title
EP0846088A4 (en) CEMENT FORMULATION
GB9407135D0 (en) Treatment of osteoporosis
GB2301644B (en) Joint forming devices
HU9500229D0 (en) Pharmaceutical composition against osteoporosis
GB9508791D0 (en) Compositions of matter
PL324924A1 (en) Application of at least one betandrenergic atagoniost as that of p substances
GB2301413B (en) Joint forming devices
EP0726497A3 (en) Photosensitive composition
ZA961245B (en) Modular structures
HUP0000125A3 (en) Liquid alendronate formulations and producing them
PL323669A1 (en) Application of alendronate in osteoporosis prevention
HUP9603529A2 (en) Femoral part of hip-joint-prothesis
GB2301643B (en) Joint forming devices
EP0837863A4 (en) DISODIUM ALENDRONATE PREPARATIONS
PL320114A1 (en) Phenyl-substituted fluoroderivatives of 4-azasteroides
GB9519654D0 (en) Stabilised phospholipid compositions
EP0981545A4 (en) TREATMENT OF OSTEOPOROSIS
EP0821961A4 (en) INHIBITOR OF NEOVASCULARIZATION
GB2302093B (en) Screed composition
ZA963825B (en) Composition of matter
IL120955A0 (en) Treatment of osteoporosis
GB2304851B (en) Fastening devices
SG64924A1 (en) Inhibiting photodecompostion of 3-substituted-2- oxindoles
HU800U (en) Fastening of knee
PL103962U1 (en) Pavement overlay piece